Skip to main content
SpringerLink
Log in

The bipolar depression drug market is expected to contract by more than $US1 billion through 2017

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Modest Drug Pipeline and Significant Generic Erosion Will Decrease the Bipolar Depression Drug Market by More Than $1 Billion Through 2017. Media Release: 3 Dec 2008. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The bipolar depression drug market is expected to contract by more than $US1 billion through 2017. Pharmacoecon. Outcomes News 569, 10 (2009). https://doi.org/10.2165/00151234-200905690-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905690-00023

Keywords

Search

Navigation